Jul 13, 2026
Q32 Bio (QTTB) Shares Soar 60% After Positive Alopecia Treatment Trial Results
Q32 Bio (QTTB) stock soared 60% after bempikibart achieved primary endpoint in Phase 2a alopecia trial, showing 35.3% SALT score reduction with clean safety.
The post Q32 Bio (QTTB) Shares Soar 60% After Positive Alopecia Treatment Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 9 minutes ago
Take-Two Interactive (TTWO) Stock Falls 2% Despite Beating Q1 Estimates Amid GTA...
- 16 minutes ago
Software Sector Rally: Atlassian (TEAM) Soars 30% While Trade Desk (TTD) Plunges...
- 17 minutes ago
Weak July Jobs Report Fuels Stock Market Rally on Fed Rate Cut Speculation
- 18 minutes ago
Twilio (TWLO) Stock Jumps 16% After Smashing Q2 Earnings and Boosting Annual Gui...
- 19 minutes ago
Akamai (AKAM) Soars 13% Following Massive $600M AI Robotics Agreement